BamSEC and AlphaSense Join Forces
Learn More

PTC Therapeutics Inc. – Material Contracts

NASDAQ: PTCT    
Share price (4/2/26): $67.77    
Market cap (4/2/26): $5.610 billion

Material Contracts Filter

EX-10.47
from 10-K 8 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.42
from 10-K 3 pages Amendment No. 6 to License Agreement
12/34/56
EX-10.1
from 10-Q 17 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ Rights Satisfaction Agreement
12/34/56
EX-10.47
from 10-K 92 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. [***] Denotes Omissions. License and Collaboration Agreement Between Ptc Therapeutics, Inc. PTC Therapeutics Hd, Inc. and Novartis Pharmaceuticals Corporation Dated as of November 27, 2024
12/34/56
EX-10.46
from 10-K 34 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. [**] Denotes Omissions. ​ ​ ​ Asset Purchase Agreement by and Between [**] and PTC Therapeutics, Inc. November 26, 2024
12/34/56
EX-10.36
from 10-K 2 pages Page 1 of 3 Page 2 of 3
12/34/56
EX-10.34
from 10-K 18 pages [Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions] ​ First Amendment to Lease Agreement
12/34/56
EX-10.2
from 10-Q 9 pages ​ Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ Amendment No. 1 to Amended and Restated Royalty Purchase Agreement and First Put Option Exercise Agreement ​
12/34/56
EX-10.1
from 10-Q 23 pages Amended and Restated Exclusive License and Supply Agreement
12/34/56
EX-10.1
from 10-Q 26 pages Employment Agreement
12/34/56
EX-10.48
from 10-K 51 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ ​ Amended and Restated Royalty Purchase Agreement ​ by and Among ​ PTC Therapeutics, Inc., ​ Royalty Pharma Investments 2019 Icav ​ and ​ Solely for the Purposes of Section 5.15 Hereof, ​ Royalty Pharma PLC ​ Dated as of October 18, 2023 ​
12/34/56
EX-10.1
from 10-Q 4 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ Amendment No. 5 to License Agreement ​
12/34/56
EX-10.1
from 8-K 24 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 55 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.1
from 10-Q 87 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56
EX-10.1
from 8-K 25 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 9 pages Consulting Agreement
12/34/56
EX-10.56
from 10-K 36 pages Stock Purchase Agreement by and Among the Investors Listed Herein and PTC Therapeutics, Inc. Dated as of October 27, 2022
12/34/56
EX-10.55
from 10-K 154 pages Each Subsidiary of the Borrower From Time to Time Party Hereto, as Guarantors, ​ the Lenders From Time to Time Party Hereto ​ and Wilmington Trust, National Association, as Administrative Agent
12/34/56
EX-10.23
from 10-K 16 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions
12/34/56